MARKET

XBIT

XBIT

Xbiotech
NASDAQ
4.180
+0.070
+1.70%
After Hours: 4.030 -0.15 -3.59% 17:27 12/07 EST
OPEN
4.159
PREV CLOSE
4.110
HIGH
4.180
LOW
4.050
VOLUME
5.52K
TURNOVER
0
52 WEEK HIGH
6.69
52 WEEK LOW
3.000
MARKET CAP
127.23M
P/E (TTM)
-5.5022
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at XBIT last week (1127-1201)?
Weekly Report · 3d ago
Weekly Report: what happened at XBIT last week (1120-1124)?
Weekly Report · 11/27 09:15
Weekly Report: what happened at XBIT last week (1113-1117)?
Weekly Report · 11/20 09:15
XBiotech Third Quarter 2023 Earnings: US$0.24 loss per share (vs US$0.42 loss in 3Q 2022)
Xbiotech reported a net loss of us$7.36m in the third quarter of 2023. Xbiotech's share price is broadly unchanged from a week ago. The company reported a loss of us$0.24 per share for the quarter.
Simply Wall St · 11/14 10:05
Weekly Report: what happened at XBIT last week (1106-1110)?
Weekly Report · 11/13 09:14
Xbiotech: Quarterly report
Press release · 11/09 21:46
Weekly Report: what happened at XBIT last week (1030-1103)?
Weekly Report · 11/06 09:14
Strong week for XBiotech (NASDAQ:XBIT) shareholders doesn't alleviate pain of three-year loss
Simply Wall St · 11/03 10:13
More
About XBIT
XBiotech Inc. is a biopharmaceutical company. The Company is engaged in advancing a pipeline of therapies by harnessing naturally occurring antibodies from patients with immunity to certain diseases. The Company develops True Human monoclonal antibodies for treating a variety of diseases. True Human monoclonal antibodies are derived from human donors that mount a natural human immune response. The Company is focused on therapies that block a potent substance known as interleukin-1 alpha (IL-1a), which mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation. IL-1a is a protein that is on or in cells of the body and is involved in the body’s response to injury or trauma, In almost all chronic and some acute injury scenarios (such as stroke or heart attack).

Webull offers XBiotech Inc stock information, including NASDAQ: XBIT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XBIT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XBIT stock methods without spending real money on the virtual paper trading platform.